From the Journals

PsA Clusters Identified for Tailored Treatment: Longitudinal Study

Share

3 Key Takeaways

  • 1

    - The study identified three distinct clusters of psoriatic arthritis based on disease severity and psoriasis involvement. - Cluster 3, characterized by severe PsA and extensive psoriasis, showed the largest improvements in treatment response. - Patients in Cluster 3 demonstrated a median reduction of -

  • 2

    5 in cDAPSA and 1

  • 3

    5% of them achieved cDAPSA remission. - Treatment with TNF inhibitors showed no statistically significant differences in treatment outcomes among the clusters. - The findings highlighted the need for personalized treatment strategies and more sensitive outcome measures.

Original Source(s)

PsA Clusters Identified for Tailored Treatment: Longitudinal Study

  • by Kathryn Wighton

  • November 26, 2024

  • 2 min

Related Content

‘Patent Dance’ Delays Biosimilars Despite FDA Shift

The FDA moves to speed biosimilar approvals, but rising patent barriers may still delay lower-cost alternatives.

FDA Pushes Faster, Cheaper Route for Biosimilar Approval

The FDA released new draft guidance to streamline biosimilar development.

Discovery of Novel Susceptibility Gene May Shed Light on Etiology of Psoriatic Arthritis Mutilans

Researchers may have uncovered genetic mechanisms underlying psoriatic arthritis mutilans.